Updated NICE Type 2 Diabetes Guidance

• Overview of key changes – A summary of what has been updated in the latest NICE guidelines for Type 2 Diabetes, and any new recommendations since the previous guidance.

• Changes to first- and second-line medication recommendations, including the expanded role of SGLT-2 inhibitors and GLP-1 receptor agonists in managing blood glucose, cardiovascular risk, and weight.

• Practical implementation for clinicians –Guidance on applying the updated recommendations in primary care settings and how to support patients through treatment changes.

  
  

Speakers:

Dr Sharvanu Saha I Consultant in AMU Diabetes and Endocrinology I St George's University Hospitals NHS Foundation Trust

Dr Gautam Narayan I ICB Clinical Lead for Cardiology I Renal and Metabolic Health Network – Primary Care